Relevant bibliographies by topics / Hepatitis viruses Prevention / Books

Books on the topic 'Hepatitis viruses Prevention'

To see the other types of publications on this topic, follow the link: Hepatitis viruses Prevention.
Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 46 books for your research on the topic 'Hepatitis viruses Prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

1936-, Willson Richard A., ed. Viral hepatitis: Diagnosis, treatment, prevention. New York: M. Dekker, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yin, Guoyou. Yi xing gan yan fan zhi 30 fa. Beijing: Jin dun, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mayfield, Eleanor. Protecting patients and professionals from blood-borne disease. [Rockville, Md.] (5600 Fishers Lane, Rockville 20857): [Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mayfield, Eleanor. Protecting patients and professionals from blood-borne disease. [Rockville, Md.] (5600 Fishers Lane, Rockville 20857): [Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Administration, United States Occupational Safety and Health. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Great Britain. Expert Advisory Group on AIDS. Guidance for clinical health care workers: Protection against infection with HIV and hepatitis viruses. London: H.M.S.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

United States. Occupational Safety and Health Administration. Enforcement procedures for the occupational exposure to Bloodborne Pathogens Standard, 29 CFR 1910.1030. Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

United States. Congress. House. Committee on Education and Labor. Subcommittee on Health and Safety. Oversight hearings on OSHA's proposed standard to protect health care workers against blood-borne pathogens including the AIDS and hepatitis B viruses: Hearings before the Subcommittee on Health and Safety of the Committee on Education and Labor, House of Representatives, One Hundred First Congress, first session .... Washington: U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

United States. Congress. House. Committee on Education and Labor. Subcommittee on Health and Safety. Oversight hearings on OSHA's proposed standard to protect health care workers against blood-borne pathogens including the AIDS and hepatitis B viruses: Hearings before the Subcommittee on Health and Safety of the Committee on Education and Labor, House of Representatives, One Hundred First Congress, first session. Washington: U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

United States. Congress. House. Committee on Education and Labor. Subcommittee on Health and Safety. Oversight hearings on OSHA's proposed standard to protect health care workers against blood-borne pathogens including the AIDS and hepatitis B viruses: Hearings before the Subcommittee on Health and Safety of the Committee on Education and Labor, House of Representatives, One Hundred First Congress, first session. Washington: U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

1968-, Zhang Weiying, and Ye Lihong, eds. Hepatitis B virus research focus. New York: Nova Science Publishers, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

United States. Congress. House. Committee on Government Reform and Oversight. Hepatitis C, silent epidemic, mute public health response: Seventh report by the Committee on Government Reform and Oversight. Washington: U.S. G.P.O., 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Occupational Safety and Health Administration, Directorate of Compliance Programs: Occupational exposure to Bloodborne Pathogens Interpretive Quips (IQs). [Washington, D.C.?]: The Directorate, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Sexually transmitted diseases sourcebook: Basic consumer health information about sexual health and the screening, diagnosis, treatment, and prevention of common sexually transmitted diseases (STDs), including chancroid, chlamydia, gonorrhea, herpes, hepatitis, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), human papillomavirus (HPV), syphilis, and trichomoniasis ; along with facts about risk factors and complications, trends and disparities in infection rates, tips for discussing STDs with sexual partners, a glossary of related terms, and resources for additional help and information. 5th ed. Detroit, MI: Omnigraphics, Inc., 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Willson, Richard. Viral Hepatitis: Diagnosis-treatment-prevention. Taylor & Francis Group, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

W, Reesink H., ed. Hepatitis C virus. 2nd ed. Basel: Karger, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

W, Reesink H., ed. Hepatitis C virus. Basel: Karger, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Willson, Richard. Viral Hepatitis: Diagnosis, Treatment, Prevention (Gastroenterology and Hepatology Series , No 4). Informa Healthcare, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Matthews, Philippa C. Infections caused by DNA viruses. Edited by Philippa C. Matthews. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198737773.003.0008.

Full text
Abstract:
This chapter consists of short notes, diagrams, and tables to summarize DNA viruses that are significant causes of disease in the tropics and subtropics. This includes pox viruses and hepatitis B virus. For ease of reference, each topic is broken down into sections, including classification, epidemiology, microbiology, pathophysiology, clinical syndromes, diagnosis, treatment, and prevention
APA, Harvard, Vancouver, ISO, and other styles
21

Matthews, Philippa C. Infections caused by RNA viruses. Edited by Philippa C. Matthews. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198737773.003.0009.

Full text
Abstract:
This chapter consists of short notes, diagrams, maps, and tables to summarize RNA viruses that are significant causes of disease in the tropics and subtropics. This includes measles, polio, hepatitis A, C, and E viruses, rabies, arboviruses, and viral haemorrhagic fevers. The chapter also includes sections on important retroviruses, HIV, and human T-lymphotropic virus. For ease of reference, each topic is broken down into sections, including classification, epidemiology, microbiology, pathophysiology, clinical syndromes, diagnosis, treatment, and prevention.
APA, Harvard, Vancouver, ISO, and other styles
22

Kourtis, Athena P., Shruti Chandramouli, Gonzague Jourdain, and Marc Bulterys. Hepatitis B Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0004.

Full text
Abstract:
Hepatitis B virus (HBV) is the most common cause of chronic viral hepatitis and hepatocellular carcinoma in the world. Worldwide, more than 250 million people are chronically infected with HBV, causing nearly 780,000 deaths each year, and mother-to-child transmission (MTCT) accounts for more than one-third of chronic HBV infections. Universal vaccination in neonates is the most effective strategy for eliminating infections worldwide. Maternal antiviral treatment during the antepartum/postpartum period for mothers with high HBV viral loads is effective in preventing HBV MTCT. Full immunization coverage is currently the only way to reach the goal of eradicating HBV infection. Operational research and, in some resource-limited settings, international funding may be essential to bring the vaccine where neonates and infants need it, including remote locations where home births are common. Continued improvements in the coverage and timeliness of HBV vaccination and education of clinicians about its importance are needed.
APA, Harvard, Vancouver, ISO, and other styles
23

G, Murphy Donald, Go Vay Liang W, United States. Digestive Diseases Coordinating Committee, and National Institute of Diabetes and Digestive and Kidney Diseases (U.S.), eds. Hepatitis B virus prevention activities in the federal government. Bethesda, MD: Digestive Diseases Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Bulterys, Marc, Julia Brotherton, and Ding-Shinn Chen. Prevention of Infection-Related Cancers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0066.

Full text
Abstract:
This chapter discusses primary prevention measures that disrupt transmission of oncogenic infections. It begins by discussing vaccination against hepatitis B virus (HBV) and human papillomavirus (HPV), two major causes of cancer for which safe and effective vaccines are currently available. It briefly discusses the importance of treatment and prophylaxis against human immunodeficiency virus type 1 (HIV-1), which potentiates the virulence of other viral infections as well as directly increasing the incidence of non-Hodgkin lymphoma. It does not discuss the treatment of HBV or hepatitis C virus (HCV) infection, since these are considered in Chapters 25 and 33. Also beyond the scope of this chapter are the randomized clinical trials currently underway to assess the efficacy and feasibility of eradication of Helicobacter pylori (Chapters 24, 31), vaccination against Epstein-Barr virus (EBV) (Chapters 24, 26, 39), or the prevention of schistosomiasis and liver flukes (Chapters 24, 33, and 52).
APA, Harvard, Vancouver, ISO, and other styles
25

Berenguer, Marina. Hepatitis C Virus and Liver Transplantation. Springer, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Berenguer, Marina. Hepatitis C Virus and Liver Transplantation. Springer, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Berenguer, Marina. Hepatitis C Virus and Liver Transplantation. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Berenguer, Marina. Hepatitis C Virus and Liver Transplantation. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Progress in hepatitis B research. New York: Nova Biomedical Books, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Denyer, Dorothy V. Progress in Hepatitis B Research. Nova Science Pub Inc, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Guidelines for Prevention of Transmission Human Immunodeficiency Virus and Hepatitis B. United States Government Printing, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Bamia, Christina, Sherri Stuver, and Lorelei Mucci. Cancer of the Liver and Biliary Tract. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0012.

Full text
Abstract:
Primary liver cancer is one of the most commonly occurring cancers globally, and is the second most common cause of cancer death worldwide. There are two major histologic forms of primary liver cancer: hepatocellular carcinoma (HCC) and cholangiocarcinoma. It is a rapidly and almost uniformly fatal disease, yet there is already sufficient knowledge about its major risk factors, many of which are modifiable, to make primary prevention effective. Primary liver cancer is one of the first common human cancer that was found to have an infectious etiology, with hepatitis B virus (HBV) and hepatitis C virus (HCV) for HCC, and parasitic liver flukes for cholangiocarcinoma. Obesity is emerging as an important risk factor, particularly in Western countries, where primary liver cancer rates appear to be increasing over time. A number of additional risk factors and potential preventive factors are considered in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
33

Thun, Michael J., Martha S. Linet, James R. Cerhan, Christopher Haiman, and David Schottenfeld. Primary Prevention of Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0062.

Full text
Abstract:
Primary prevention has enormous potential to reduce the human, social, and economic costs of cancer worldwide. The following sections discuss the development and application of preventive interventions in six broad areas of public health: tobacco control, the prevention of obesity and physical inactivity, prevention of infection-related cancers, protection against excessive exposure to ultraviolet light, preventive drug therapies (chemoprevention), and the regulation of carcinogenic exposures. All of these areas affect multiple types of cancer and massive numbers of people. Different interventions are at varying stages of development. For example, effective, evidence-based approaches have been developed over several decades to reduce tobacco use, prevent chronic infection with hepatitis B virus, protect children from excessive sun exposure, regulate exposures in high-income countries, and reduce breast cancer incidence and recurrence in high-risk women. More recent efforts are seeking to identify upstream measures to prevent excessive weight gain, reduce caloric intake, and increase physical activity.
APA, Harvard, Vancouver, ISO, and other styles
34

Centers for Disease Control (U.S.) and National Institute for Occupational Safety and Health., eds. A Curriculum guide for public-safety and emergency-response workers: Prevention of transmission of human immunodeficiency virus and hepatitis B virus. Atlanta, Ga: Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Oldstone, Michael B. A. Viruses, Plagues, and History. Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780190056780.001.0001.

Full text
Abstract:
“Viruses, Plagues, & History” focuses on the effects of viral diseases on human history. Written by an eminent internationally respected virologist, it couples the fabric of history with major concepts developed in virology, immunology, vaccination, and accounts by people who first had, saw and acted at the times these events occurred. Much of the preventive and therapeutic progress (vaccines, antiviral drugs) has been made in the last 60 years. Many of those who played commanding roles in the fight to understand, control and eradicate viruses and viral diseases are (were) personally known to the author and several episodes described in this book reflect their input. The book records the amazing accomplishments that led to the control of lethal and disabling viral diseases caused by Smallpox, Yellow Fever, Measles, Polio, Hepatitis A, B and C, and HIV. These six success stories are contrasted with viral infections currently out of control—COVID-19, Ebola virus, Lassa Fever virus, Hantavirus, West Nile virus, and Zika. Influenza, under reasonable containment at present, but with the potential to revert to a world-wide pandemic similar to 1918–1919 where over 50 million people were killed. The new platforms to develop inhibitory and prophylactic vaccines to limit these and other viral diseases is contrasted to the anti-vaccine movement and the false prophets of autism.
APA, Harvard, Vancouver, ISO, and other styles
36

Burchell, Ann, and Eduardo Franco1. The impact of immunization on cancer control: the example of HPV vaccination. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199550173.003.0006.

Full text
Abstract:
Chapter 6 reviews briefly the role of infections as causal agents in cancer, describes anti-hepatitis B virus (HBV) immunization as the first cancer vaccine paradigm, and finally focuses on the latest paradigm of prophylactic vaccination against human papillomavirus (HPV) infection as the new front in cancer prevention.
APA, Harvard, Vancouver, ISO, and other styles
37

National Institute for Occupational Safety and Health. and Centers for Disease Control (U.S.), eds. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers: A response to P.L. 100-607, the Health Omnibus Programs Extension Act of 1988. Atlanta, Ga: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Russi, Mark. Biological Hazards. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190662677.003.0016.

Full text
Abstract:
This chapter describes various biological hazards and their impact on workers and others. A major focus of the chapter is biological hazards in healthcare and laboratory settings, including exposure to bloodborne pathogens and prevention of diseases related to them. Sections deal with sharps injuries, HIV/AIDS, hepatitis B virus, hepatitis C virus, tuberculosis, and other infectious diseases that can be acquired in the work environment via direct contact, droplet or airborne spread, or fecal-oral transmission. In addition, infectious agents spread by animal contact or arthropod vectors in a broad range of settings will be addressed. Newly emerging infectious or re-emerging infections, such as those due to H5N1 and novel H1N1 influenza, Middle Eastern respiratory syndrome (MERS), and Ebola Virus Disease (EVD) as well as agents associated with bioterrorism are discussed.
APA, Harvard, Vancouver, ISO, and other styles
39

Thun, Michael J., Christopher P. Wild, and Graham Colditz. Framework for Understanding Cancer Prevention. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0061.

Full text
Abstract:
The worldwide increase in the number of people affected by cancer and the costs of cancer care has increased the urgency of efforts to translate knowledge about the causes of cancer into effective preventive interventions. A wide range of interventions has proven to be effective for cancer prevention, either by reducing exposure to known causes of human cancer or by disrupting the multistage progression of tumors. Examples of progress include the up to 40% decrease in the age-standardized lung cancer incidence rate among men in high- and middle-income countries due to tobacco control; the 30% decrease in colorectal cancer incidence in the United States from widespread screening and the removal of precursor adenomatous tumors; the decreased prevalence of chronic hepatitis B virus (HBV) infection in East Asia due to neonatal vaccination; and protection against excessive sun exposure and decreased incidence of melanoma and keratinocytic carcinomas in Australia.
APA, Harvard, Vancouver, ISO, and other styles
40

(Editor), P. Coursaget, and M. J. Tong (Editor), eds. Progress in Hepatitis B Immunization. John Libbey & Co Ltd, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Curriculum Guide for Public-Safety & Emergency-Response Workers: Prevention of Transmission of HIV & Hepatitis B Virus. Diane Pub., 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

California. Office of Health Care Services., ed. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. [Sacramento, Calif.]: California Dept. of Corrections, Office of Health Care Services, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

United States. Dept. of Health and Human Services. and Centers for Disease Control (U.S.), eds. A Curriculum guide for public-safety and emergency-response workers: Prevention of transmission of human immunodeficiency virus and hepatitis B virus. Atlanta, Ga: Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. [Atlanta, Ga.?: Centers for Disease Control, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Guidelines for Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public Safety Workers Response to p. United States Government Printing, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Center for Infectious Diseases (U.S.) and National Institute for Occupational Safety and Health., eds. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers: A response to P.L. 100-607, The Health Omnibus Programs Extension Act of 1988. Atlanta, Ga: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Hepatitis viruses Prevention' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography